C07K 16/22
Against growth factors
Official title: against growth factors {; against growth regulators}
C07K16/22 (Against growth factors) appears on 2,796 US grants and 5,143 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,796
- Published applications
- 5,143
- Assignees
- 1,513
- Inventors
- 7,541
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 0 | 0 |
| 1991 | 5 | 0 |
| 1992 | 10 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 15 | 0 |
| 1996 | 14 | 0 |
| 1997 | 33 | 0 |
| 1998 | 62 | 0 |
| 1999 | 49 | 0 |
| 2000 | 30 | 0 |
| 2001 | 39 | 6 |
| 2002 | 34 | 52 |
| 2003 | 37 | 79 |
| 2004 | 28 | 79 |
| 2005 | 15 | 82 |
| 2006 | 39 | 85 |
| 2007 | 39 | 132 |
| 2008 | 36 | 125 |
| 2009 | 56 | 147 |
| 2010 | 92 | 186 |
| 2011 | 79 | 207 |
| 2012 | 101 | 193 |
| 2013 | 110 | 241 |
| 2014 | 133 | 277 |
| 2015 | 138 | 286 |
| 2016 | 149 | 271 |
| 2017 | 154 | 290 |
| 2018 | 145 | 258 |
| 2019 | 157 | 285 |
| 2020 | 167 | 269 |
| 2021 | 174 | 328 |
| 2022 | 145 | 273 |
| 2023 | 130 | 263 |
| 2024 | 134 | 278 |
| 2025 | 122 | 239 |
| 2026 | 96 | 212 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TGFbeta1-binding immunoglobulins and use thereof6 Oct 2026US 12,753,226 B2Scholar Rock, Inc.
- Methods for treating bone-related disorders22 Sep 2026US 12,740,963 B2University of Maryland, Baltimore
- Modulation of Wnt5a to treat glaucoma22 Sep 2026US 12,741,996 B2The Regents of the University of California
- Humanized and variant TGF-β3 specific antibodies and methods and uses thereof15 Sep 2026US 12,735,475 B2Centre Hospitalier Universitaire Vaudois
- Anti-GARP/TGF-β antibodies and methods of use15 Sep 2026US 12,735,476 B2Shanghai Henlius Biotech, Inc.
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308231 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308232 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308233 A1Regeneron Pharmaceuticals, Inc.
- Methods and compositions for treating cancer8 Oct 2026US 2026/0308241 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Methods for producing members of specific binding pairs849US 5,733,743 ACambridge Antibody Technology Limited · 1998
- Production of anti-self antibodies from antibody segment repertoires and displayed on phage541US 5,885,793 ACambridge Antibody Technology Limited · 1999
- Polypeptide variants521US 6,528,624 B1Genentech, Inc. · 2003
- Optimized Fc variants463US 7,317,091 B2Xencor, Inc. · 2008